China Vanke’s Stock Price Dips to 3.58 HKD, Recording a Sharp 7.73% Drop

China Vanke (2202)

3.58 HKD -0.30 (-7.73%) Volume: 186.86M

China Vanke’s stock price stands at 3.58 HKD, witnessing a steep drop of 7.73% this trading session, with a high trading volume of 186.86M shares. The real estate giant has seen a significant decrease in its year-to-date percentage change, plummeting by 31.95%, highlighting the volatility of its market performance.

Latest developments on China Vanke

China Vanke (H) shares hit a record low today after proposing a delay in bond payments, causing its bonds to extend losses as the developer seeks onshore repayment postponement for the first time. This move has thrust the China property crisis back into the spotlight, triggering a slide in the property sector as Vanke faces a worsening debt crisis. Despite this, China and Hong Kong shares edged up on domestic AI optimism, with Vanke slipping 8.5% at one point and some bonds hitting a record low.

A look at China Vanke Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Vanke (H) has received a high score of 5 in the Value category, indicating a positive long-term outlook for the company’s financial health and stability. This suggests that the company is undervalued relative to its intrinsic worth, making it an attractive investment opportunity for potential investors.

However, China Vanke (H) has received lower scores in other areas such as Dividend, Growth, Resilience, and Momentum. With scores of 1, 2, 2, and 2 respectively, this indicates that the company may face challenges in terms of dividend payouts, growth potential, ability to withstand economic shocks, and market momentum. Investors should consider these factors when assessing the overall outlook for China Vanke (H) in the long run.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma